Suehiro K.,1990
Suehiro K., Miyata T., Takeya H., Takamatsu J., Saito H., Marakawa M., Okamura T., Niko Y., Iwanaga S. Blood clotting factor IX Nagoya 3: the molecular defect of zymogen activation caused by an arginine-145 to histidine substitution. - Thromb.Res., 1990, v. 60, p. 311-320.